[1]
W. Bębenek, A. Marczak, and A. Rogalska, “Evaluation of the role of oxidative stress in the anticancer effects of CHK1 and PARP-1 inhibitors in HepG2 cells”, FBOe, vol. 18, pp. 7–8, Sep. 2024.